Addition of pentoxifylline to pegylated interferon-alpha-2a and ribavirin improves sustained virological response to chronic hepatitis C virus: a randomized clinical trial
Journal Title: Annals of Hepatology - Year 2013, Vol 12, Issue 2
Abstract
[b]Background and aim.[/b] The commonly accepted treatment for hepatitis C virus (HCV) infection, pegylated interferon alpha (PEG INF-alpha) and ribavirin, leads to 50-60% of sustained virological response (SVR). On the other hand, pentoxifylline (PTX) possesses antiviral and hepatoprotector properties. [b]Aim[/b]. To investigate whether the addition of PTX to conventional hepatitis C treatment increases SVR. [b]Material and methods. [/b]Seventy two patients of both genders were studied in a randomized fashion; the diagnosis of chronic HCV infection was made according to clinical and laboratory criteria and histopathologically classified according to METAVIR scoring system criteria. HCV viral load was tested by PCR, baseline, and after 6 months of treatment, as well as anti-HCV, anti-hepatitis B virus , and anti-human immunodeficiency virus antibodies by enzyme-linked immunosorbent assay. During 48 weeks, control group patients were treated with PEG INFalpha- 2a plus ribavirin. PTX was administered to Experimental Group patients prior to the treatment. [b]Results[/b]. Demographic data were similar in both groups. Experimental- and control-group subjects were at F2 and F3 states according to the METAVIR classification. The most common HCV genotypes were 1a and 1b (39% in the control group in each case, and 42% in the experimental group in each case). At the end of the study, hepatic enzymes and viral load decreased in both groups to similar values. SVR in the experimental group increased significantly (p < 0.05) when compared with standard therapy alone. [b]Conclusion[/b]. Addition of PTX to conventional chronic hepatitis C treatment may increase the percentage of patients with SVR.
Authors and Affiliations
Miguel Jiménez-Luévano, José Lerma-Díaz, Georgina Hernández-Flores, Alejandro Bravo-Cuellar
Keywords
Related Articles
- EP ID EP78258
- DOI -
- Views 150
- Downloads 0
Isolated Intrapulmonary Vascular Dilatations and the Risk of Developing Hepatopulmonary Syndrome in Liver Transplant Candidates
Background. The natural history of intrapulmonary vascular dilations (IPVD) and their impact on patient outcomes in the setting of portal hypertension has only been described in small series. Aims. To assess the developm...
The effects of pegylated interferon alpha 2b on bile-duct ligation induced liver fibrosis in rats
Objective. To test the effects of peginterferon in an unrecoverable model of bile-duct ligation (BDL) induced liver fibrosis. Material and methods. Thirty-seven Wistar rats were divided into five groups: group 1, BDL + p...
Ongoing alcohol consumptions counteracts the benefits of sustained virological response in patients with well compensated hepatitis C cirrhosis: an observational study
Protective effect of four Mexican plants against CCl[sub]4[/sub]-induced damage on the Huh7 human hepatoma cell line
Background. Centaurea americana, Krameria ramosissima, Juglans mollis and Turnera diffusa are used by traditional healers in the northeastern region of Mexico to protect against liver damage. However, the hepatoprotectiv...
Prevalence and factors associated with the presence of Abnormal Function Liver Tests in patients with ulcerative colit
Aim. To investigate the prevalence of abnormal function liver tests and risk factors associated with their development in Mexican patients with UC. Methods. A total of 200 patients with confirmed diagnosis of UC were eva...